An agonist of receptors, adrenergic alpha-2 that is used in veterinary medicine for its analgesic and sedative properties. It is the racemate of dexmedetomidine.
Administered intravenously, dexmedetomidine is indicated for the sedation of initially intubated and mechanically ventilated patients during treatment in intensive care settings, and for the sedation of non-intubated patients prior to and/or during surgery and other procedures. It is also available as a buccally- or sublingually-administered dissolvable film for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder.
Theodor Bilharz Research Institute, Giza, Egypt
Gangnam Severance Hospital, Seoul, Korea, Republic of
Shahid Mohammadi hospital, Bandar Abbas, Hormozgan, Iran, Islamic Republic of
Montefiore Medical Center, Bronx, New York, United States
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
Theodor Bilharz Research Institute, Giza, Egypt
Severance hospital, Seoul, Korea, Republic of
Department of Anesthesiology and Pain Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea, Republic of
GangnamSH, Seoul, Korea, Republic of
Departement of Anesthesiology and Intensive Care of the University of Rome La Sapienza, Rome, Italy
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.